Literature DB >> 1537370

Thymic rebound following successful chemotherapy of B-lymphoma in an adolescent boy.

K Leibundgut1, U Willi, H J Plüss.   

Abstract

Four months after termination of successful chemotherapy for epipharyngeal B-non-Hodgkin lymphoma, an enlarging anterior mediastinal mass was discovered in a 15-year-old boy. There was no other suspicion of tumour recurrence. A simple thymic rebound was likely and a conservative management was chosen. Follow up for more than 12 months was uneventful. The frequency of thymic hyperplasia after termination of chemotherapy is discussed. It is a benign immunological rebound phenomenon and does not require operative intervention.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537370     DOI: 10.1007/bf01958950

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Thymic rebound in an adult following chemotherapy for testicular cancer.

Authors:  D M Tait; P Goldstraw; J E Husband
Journal:  Eur J Surg Oncol       Date:  1986-12       Impact factor: 4.424

2.  Thymic hyperplasia following chemotherapy of a testicular germ cell tumor. Immunohistological evidence for a simple rebound phenomenon.

Authors:  W Düe; K P Dieckmann; H Stein
Journal:  Cancer       Date:  1989-02-01       Impact factor: 6.860

3.  Rebound enlargement of the thymus after successful corrective surgery for transposition of the great vessels.

Authors:  G Rizk; L Cueto; K Amplatz
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1972-11

4.  Thymic hyperplasia in children recovering from thermal burns.

Authors:  D W Gelfand; A S Goldman; E J Law; B G MacMillan; D Larson; S Abston; J T Schreiber
Journal:  J Trauma       Date:  1972-09

5.  [Reactive benign thymus hyperplasia following cytostatic chemotherapy].

Authors:  K P Dieckmann; W Düe; K J Bauknecht; B Hamm
Journal:  Dtsch Med Wochenschr       Date:  1988-04-15       Impact factor: 0.628

6.  Diffuse thymic hyperplasia following chemotherapy for nodular sclerosing Hodgkin's disease. An immunologic rebound phenomenon?

Authors:  M S Shin; K J Ho
Journal:  Cancer       Date:  1983-01-01       Impact factor: 6.860

7.  Regrowth and overgrowth of the thymus after atrophy induced by the oral administration of adrenocorticosteroids to human infants.

Authors:  J CAFFEY; R SILBEY
Journal:  Pediatrics       Date:  1960-11       Impact factor: 7.124

8.  Thymic atrophy and regrowth in response to chemotherapy: CT evaluation.

Authors:  P L Choyke; R K Zeman; J E Gootenberg; J N Greenberg; F Hoffer; J A Frank
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Thymic hyperplasia following successful chemotherapy. A report of two cases and review of the literature.

Authors:  L Carmosino; A DiBenedetto; S Feffer
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

10.  Thymic rebound after treatment of childhood tumors.

Authors:  M Cohen; C A Hill; A Cangir; M P Sullivan
Journal:  AJR Am J Roentgenol       Date:  1980-07       Impact factor: 3.959

View more
  2 in total

1.  Rebound thymic hyperplasia detected by 18F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer.

Authors:  Tae Joo Jeon; Yong Sang Lee; Jae-Hoon Lee; Hang Seok Chang; Young Hoon Ryu
Journal:  Thyroid       Date:  2014-08-20       Impact factor: 6.568

2.  Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge.

Authors:  A Feldges; H P Wagner; B Bubeck; B Kehrer; G Ries; U Schmid; P Waibel
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.